LuciQuiza

Sobre este medicamento

Originator: Vanflyta by DAIICHI SANKYO INC · Manufacturer: Lucius Pharma. Indication & Dosage: LuciQuiza (Quizartinib), generic Vanflyta is a prescription medicine used to treat treatment of newly diagnosed acute myeloid leukemia (AML) in adult patients with a confirmed FLT3 internal tandem duplication (ITD)-positive mutation. Quizartinib is utilized as part of a combination regimen with standard chemotherapy and as maintenance monotherapy following the completion of chemotherapy. LuciQuiza manufactured by Lucius Pharma Ltd. in Laos. Quizartinib has to take orally once a daily with or without food as directed by patients doctor. Side Effects: The most common side effects of Quizartinib are: Nausea, vomiting, diarrhea, abdominal pain, mouth sores, decreased appetite, headache, or trouble sleeping. The above information comes from the Internet. Please consult with doctor for medical advice.

Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.